Sign inCreate account

Report workspace tools

NCT07480811NOT_YET_RECRUITINGanonymous

The Effect of the DASH Diet on Clinical and Metabolic Parameters in Children With MASLD

Sponsor

Source record

Antalya Training and Research Hospital

Phase

Source record

Not Yet Recruiting

Modality

AI-normalized

protein therapy

Target

AI-normalized

Dietary modification focusing on anti-inflammatory and antioxidant properties to improve metabolic health in pediatric patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).

Indication / condition

AI-normalized

Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Intervention

Source record

DASH Diet, Standart Diet, Physical Activity

Source & freshness

Source record

NCT ID

NCT07480811

Original source

ClinicalTrials.gov

Source last updated

Mar 18, 2026

Ingested at

Jun 09, 2026

Internal sync

Jun 09, 2026

Model version

trialsignal-ai-v1

Normalized confidence

96%

Validation status

validated

Open original registry record
View original source fields

NCT ID

NCT07480811

Title

The Effect of the DASH Diet on Clinical and Metabolic Parameters in Children With MASLD

Sponsor

Antalya Training and Research Hospital

Status

NOT_YET_RECRUITING

Phase

Not Yet Recruiting

Condition raw

Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Condition normalized

Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Modality raw

protein therapy

Modality normalized

protein therapy

Target raw

Dietary modification focusing on anti-inflammatory and antioxidant properties to improve metabolic health in pediatric patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).

Target normalized

Dietary modification focusing on anti-inflammatory and antioxidant properties to improve metabolic health in pediatric patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).

Interventions

DASH Diet, Standart Diet, Physical Activity

Public preview

Source record

The clinical trial sponsored by Antalya Training and Research Hospital aims to evaluate the efficacy of the DASH diet in managing MASLD in children aged 11-18 years. Given the rising prevalence of MASLD alongside childhood obesity, this study addresses a significant unmet medical need. The market for pediatric liver disease management is expanding, particularly as awareness of non-alcoholic fatty liver disease grows. The trial's focus on dietary interventions may position it favorably against pharmacological approaches, which are currently limited. Successful outcomes could lead to the establishment of dietary guidelines and interventions that could be monetized through partnerships with healthcare providers and nutrition-focused organizations.

AI-generated analysis supports research triage only. Verify source records, publications, sponsor disclosures and IP databases before making diligence decisions. Model: trialsignal-ai-v1.

Report access

Create an account to unlock this report

Choose the access model that matches the job: one urgent report, reusable credits for project work, or unlimited monthly access with AI and folders.

Full protocol, outcomes, eligibility, contacts and results sections
Patent/IP landscape with verified records when available
Board-ready PDF export with source provenance
Save to folders and synthesize multiple assets in premium workspace
Create account
Sign in

Create a free account first, then unlock a single report, buy credits or subscribe.

TrialSignal

Clinical trial intelligence report

The Effect of the DASH Diet on Clinical and Metabolic Parameters in Children With MASLD

Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.

Generated

Jun 13, 2026

NCT ID

NCT07480811

Status

NOT_YET_RECRUITING

Phase

Not Yet Recruiting

Sponsor

Antalya Training and Research Hospital

Executive brief

Investment-Ready Snapshot

The clinical trial sponsored by Antalya Training and Research Hospital aims to evaluate the efficacy of the DASH diet in managing MASLD in children aged 11-18 years. Given the rising prevalence of MASLD alongside childhood obesity, this study addresses a significant unmet medical need. The market for pediatric liver disease management is expanding, particularly as awareness of non-alcoholic fatty liver disease grows. The trial's focus on dietary interventions may position it favorably against pharmacological approaches, which are currently limited. Successful outcomes could lead to the establishment of dietary guidelines and interventions that could be monetized through partnerships with healthcare providers and nutrition-focused organizations.

Source & freshness

Provenance

SourceClinicalTrials.gov
Source updatedMar 18, 2026
Internal syncJun 09, 2026
Model versiontrialsignal-ai-v1

https://clinicaltrials.gov/study/NCT07480811

Indication

Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Modality

protein therapy

Target

Dietary modification focusing on anti-inflammatory and antioxidant properties to improve metabolic health in pediatric patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).

Intervention

DASH Diet, Standart Diet, Physical Activity

Source record

Protocol Description

Detailed source ingestion pending.

Source record

Outcome Measures

Detailed source ingestion pending.

Source record

Eligibility

Detailed source ingestion pending.

AI analysis

Known Results And Readout Context

Detailed source ingestion pending.

IP intelligence

Patent And IP Landscape

Detailed source ingestion pending.

Source record

Contacts

Detailed source ingestion pending.